The PK-Eye™ uses an in house simulated vitreous to mimic the clearance profiles of clinical therapeutic proteins and to mimic different patient populations. The simulated vitreous has been validated to estimate the human pharmacokinetic properties for proteins/peptides, small molecules and implants. Different type of simulated vitreous are currently being tested.